Osteoblastic meningiomas: clinico-pathological and immunohistochemical features of an uncommon variant

V Barresi1, M Caffo, A Ieni

  • 1Department of Human Pathology, Azienda Ospedaliera Universitaria Polyclinic G. Martino, Via Consolare Valeria, 98125, Messina, Italy. vbarresi@unime.it

Insights

Osteoblastic meningiomas, a rare tumor variant, show slow growth and good prognosis. Bone formation in these tumors may occur via calcification or a metaplastic mechanism, as suggested by histological and immunohistochemical findings.

Area of Science:

  • Neuropathology
  • Bone Biology
  • Tumor Histogenesis

Background:

  • Osteoblastic meningioma is a rare meningioma subtype characterized by bone spicules.
  • The histogenesis of osteoblastic meningioma remains unclear.

Purpose of the Study:

  • To investigate the clinical and histological features of osteoblastic meningiomas.
  • To examine the expression of bone matrix proteins (osteocalcin and osteopontin) in osteoblastic meningiomas.
  • To elucidate the potential pathways of bone formation in this rare tumor variant.

Main Methods:

  • Histological examination of seven osteoblastic meningioma cases.
  • Immunohistochemical analysis for osteocalcin and osteopontin expression.
  • Correlation of histological findings with clinical outcomes.

Main Results:

  • None of the seven cases showed recurrence or significant regrowth after partial resection, indicating an indolent nature.
  • Bone formation pathways varied: 5/7 cases showed osseous components with psammoma bodies and calcification, while one case suggested enchondral ossification.
  • Osteocalcin was positive in bone spicules, and osteopontin was expressed in osteoclasts, bone, calcifications, psammoma bodies, and neoplastic cells in cases lacking calcification.

Conclusions:

  • Osteoblastic meningioma is an indolent variant with a good prognosis.
  • Bone formation in osteoblastic meningioma can occur through calcification or a metaplastic process, potentially involving osteopontin expression by neoplastic cells.